Literature DB >> 11926349

Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe.

Lennart Hansson1, Adam Lloyd, Pippa Anderson, Zoe Kopp.   

Abstract

AIM: To estimate the burden of failing to achieve targets for blood pressure (BP) control in France, Germany, Italy, Sweden and the UK.
METHODS: A cost of illness model was constructed to estimate the impact of uncontrolled hypertension to each national healthcare system. Prevalence of uncontrolled hypertension was taken from published data. Relationships between achieved BP and the cardiovascular events of symptomatic acute myocardial infarction, congestive heart failure and stroke were estimated from the HOT study. Costs were taken from public sources. The acute medical costs of these events were estimated at current prevalence of uncontrolled hypertension and if BP were treated to target.
RESULTS: The model estimated that 29 million adults in the five countries (13% population) have BP levels above 160/95 mmHg, and an additional 46 million (21% population) have BP in the range 140/90-160/95 mmHg. The model estimated that healthcare system costs of 1.26 billion euros could be avoided if hypertension management did achieve BP targets. This does not consider the cost of interventions required to reduce the risk of cardiovascular disease.
CONCLUSIONS: Failing to achieve BP targets contributes substantially to healthcare system costs and preventable events in the countries studies.

Entities:  

Mesh:

Year:  2002        PMID: 11926349     DOI: 10.1080/080370502753543945

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  11 in total

1.  Costs of inflammatory bowel disease in Germany.

Authors:  Renee Stark; Hans-Helmut König; Reiner Leidl
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 2.  Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment.

Authors:  Francesco Vittorio Costa
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-10

3.  Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy.

Authors:  Eberhard Wille; Jürgen Scholze; Eduardo Alegria; Claudio Ferri; Sue Langham; Warren Stevens; David Jeffries; Kerstin Uhl-Hochgraeber
Journal:  Eur J Health Econ       Date:  2010-04-20

4.  Financial and health costs of uncontrolled blood pressure in the United Kingdom.

Authors:  Adam Lloyd; Claudia Schmieder; Nick Marchant
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  The economic burden of stroke in the United Kingdom.

Authors:  Penny Youman; Koo Wilson; Farzaneh Harraf; Lalit Kalra
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

6.  Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model.

Authors:  Jürgen Scholze; Eduardo Alegria; Claudio Ferri; Sue Langham; Warren Stevens; David Jeffries; Kerstin Uhl-Hochgraeber
Journal:  BMC Public Health       Date:  2010-09-02       Impact factor: 3.295

7.  Trends in Prescription and Determinants of Persistence to Antihypertensive Therapy : The PAPEETE Study.

Authors:  Francesco Vittorio Costa; Luca Degli Esposti; Carlo Cerra; Chiara Veronesi; Stefano Buda
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-03

8.  National survey on excellence centers and reference centers for hypertension diagnosis and treatment: geographical distribution, medical facilities and diagnostic opportunities.

Authors:  Giuliano Tocci; Nicola De Luca; Riccardo Sarzani; Ettore Ambrosioni; Claudio Borghi; Santina Cottone; Cesare Cuspidi; Francesco Fallo; Claudio Ferri; Alberto Morganti; Maria Lorenza Muiesan; Leonardo Sechi; Agostino Virdis; Giuseppe Mancia; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-26

9.  Hypertension knowledge, heart healthy lifestyle practices and medication adherence among adults with hypertension.

Authors:  Hawa Abu; Hanan Aboumatar; Kathryn A Carson; Robert Goldberg; Lisa A Cooper
Journal:  Eur J Pers Cent Healthc       Date:  2018-04-30

Review 10.  The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target.

Authors:  Jean-Jacques Mourad
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.